Display options
Share it on

J Clin Biochem Nutr. 2020 Sep;67(2):179-187. doi: 10.3164/jcbn.20-24. Epub 2020 Jun 09.

Reduction of stearoyl-CoA desaturase (SCD) contributes muscle atrophy through the excess endoplasmic reticulum stress in chronic kidney disease.

Journal of clinical biochemistry and nutrition

Yuki Niida, Masashi Masuda, Yuichiro Adachi, Aika Yoshizawa, Hirokazu Ohminami, Yuki Mori, Kohta Ohnishi, Hisami Yamanaka-Okumura, Takayuki Uchida, Takeshi Nikawa, Hironori Yamamoto, Makoto Miyazaki, Yutaka Taketani

Affiliations

  1. Department of Clinical Nutrition and Food Management, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
  2. Department of Nutritional Physiology, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
  3. Department of Health and Nutrition, Faculty of Human Life, Jin-ai University, 3-1-1 Ohde-cho, Fukui 915-8586, Japan.
  4. Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui 910-1193, Japan.
  5. Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Denver, Aurora, Colorado 80045, USA.

PMID: 33041516 PMCID: PMC7533850 DOI: 10.3164/jcbn.20-24

Abstract

Skeletal muscle atrophy is associated with mortality and poor prognosis in patients with chronic kidney disease (CKD). However, underlying mechanism by which CKD causes muscle atrophy has not been completely understood. The quality of lipids (lipoquality), which is defined as the functional features of diverse lipid species, has recently been recognized as the pathology of various diseases. In this study, we investigated the roles of the stearoyl-CoA desaturase (SCD), which catalyzes the conversion of saturated fatty acids into monounsaturated fatty acids, in skeletal muscle on muscle atrophy in CKD model animals. In comparison to control rats, CKD rats decreased the SCD activity and its gene expression in atrophic gastrocnemius muscle. Next, oleic acid blocked the reduction of the thickness of C2C12 myotubes and the increase of the endoplasmic reticulum stress induced by SCD inhibitor. Furthermore, endoplasmic reticulum stress inhibitor ameliorated CKD-induced muscle atrophy (the weakness of grip strength and the decrease of muscle fiber size of gastrocnemius muscle) in mice and the reduction of the thickness of C2C12 myotubes by SCD inhibitor. These results suggest that the repression of SCD activity causes muscle atrophy through excessive endoplasmic reticulum stress in CKD.

Copyright © 2020 JCBN.

Keywords: chronic kidney disease; endoplasmic reticulum stress; saturated fatty acid; skeletal muscle atrophy; stearoyl-CoA desaturase

Conflict of interest statement

No potential conflicts of interest were disclosed.

References

  1. Nat Rev Mol Cell Biol. 2012 Jan 18;13(2):89-102 - PubMed
  2. Am J Physiol Cell Physiol. 2018 Jun 1;314(6):C721-C731 - PubMed
  3. J Lipid Res. 2012 Aug;53(8):1543-52 - PubMed
  4. Sci Rep. 2017 Feb 02;7:41572 - PubMed
  5. Am J Physiol Endocrinol Metab. 2014 Sep 15;307(6):E469-84 - PubMed
  6. J Clin Invest. 2015 Oct 26;125(12):4544-58 - PubMed
  7. Cell. 2004 Apr 30;117(3):399-412 - PubMed
  8. Biochim Biophys Acta. 2012 May;1818(5):1309-17 - PubMed
  9. J Clin Biochem Nutr. 2019 Jul;65(1):23-28 - PubMed
  10. Prostaglandins Leukot Essent Fatty Acids. 2003 Feb;68(2):113-21 - PubMed
  11. Am J Physiol Renal Physiol. 2017 Jan 1;312(1):F230-F244 - PubMed
  12. Biochimie. 2013 Nov;95(11):1971-9 - PubMed
  13. FEBS J. 2019 Jan;286(2):379-398 - PubMed
  14. Endocrinology. 2008 May;149(5):2293-305 - PubMed
  15. J Lipid Res. 1985 Mar;26(3):288-97 - PubMed
  16. J Clin Biochem Nutr. 2014 Jul;55(1):15-25 - PubMed
  17. Biochem Biophys Res Commun. 2018 Dec 2;506(4):773-779 - PubMed
  18. Nat Rev Mol Cell Biol. 2008 Feb;9(2):112-24 - PubMed
  19. Diabetologia. 2013 Jun;56(6):1372-82 - PubMed
  20. FASEB J. 2004 Jan;18(1):39-51 - PubMed
  21. Lipids Health Dis. 2016 Sep 27;15(1):167 - PubMed
  22. Oxid Med Cell Longev. 2017;2017:2739721 - PubMed
  23. J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):323-337 - PubMed
  24. PLoS One. 2019 Dec 31;14(12):e0226940 - PubMed
  25. J Lipid Res. 2016 Aug;57(8):1329-38 - PubMed
  26. Nat Rev Nephrol. 2014 Sep;10(9):504-16 - PubMed
  27. J Biol Chem. 2015 Oct 16;290(42):25497-511 - PubMed
  28. J Clin Biochem Nutr. 2018 Nov;63(3):181-191 - PubMed
  29. Physiol Rep. 2017 Dec;5(23): - PubMed
  30. Biochem J. 2010 Aug 1;429(3):583-92 - PubMed
  31. J Clin Biochem Nutr. 2012 Jul;51(1):27-32 - PubMed
  32. J Ren Nutr. 2013 Mar;23(2):77-90 - PubMed
  33. Clin Exp Nephrol. 2017 Mar;21(Suppl 1):27-36 - PubMed

Publication Types

Grant support